Table 2.
Serum laboratory data of the 40 patients with end-stage liver disease stratified according to the presence or absence of ascites
| All patients (n = 40) | Ascites (n = 17) | Non-ascites (n = 23) | P value | |
| INR | 1.40 ± 0.31 | 1.53 ± 0.34 | 1.30 ± 0.25 | 0.0171 |
| Haemoglobin, g/L | 121.00 ± 23.80 | 108.60 ± 24.00 | 130.10 ± 19.20 | 0.003 |
| Creatinine, mg/dL | 1.19 ± 1.02 | 1.43 ± 1.49 | 1.01 ± 0.39 | 0.3281 |
| Total protein, g/L | 72.20 ± 8.70 | 68.80 ± 8.80 | 74.70 ± 7.90 | 0.032 |
| Albumin, g/L | 34.80 ± 6.70 | 32.00 ± 6.90 | 37.00 ± 5.90 | 0.019 |
| Total bilirubin, mg/dL | 4.67 ± 9.61 | 6.68 ± 11.41 | 3.19 ± 7.97 | 0.0041 |
| Sodium, mmol/L | 137.00 ± 5.00 | 134.00 ± 5.00 | 139.00 ± 4.00 | < 0.001 |
Values obtained maximum ± 7 d of respiratory tests day.
1
Mann-Whitney rank sum test was used. Statistical significance tested with Student’s t test between ascites and non-ascites groups. INR: International normalised ratio for prothrombin time.